Friday March 19 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z
Cytomegalovirus (CMV) News and Headlines
Cytomegalovirus (CMV) News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Cytomegalovirus (CMV) news alerts.
Site Map > Biotechnology News > Health News > Cytomegalovirus (CMV).

Cytomegalovirus Therapy: New cytomegalovirus therapy research reported from University Hospital, Microbiology Institute
NewsRX:  similar ...
Cytomegalovirus in inflammatory bowel disease: Pathogen or innocent bystander?
Inflammatory Bowel Diseases:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
PR Newswire:  similar ...
Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two separate viral proteins
Cell Death and Differentiation:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Montana's News Station:  similar ...
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence
Journal of Cancer:  similar ...
Cytomegalovirus Pneumonia: Community-Acquired Pneumonia in Immunocompetent Hosts
MDLinx:  similar ...
Chimerix Initiates Phase 2 Study Of CMX001 In Stem Cell Transplant Recipients Seropositive For Cytomegalovirus
Bioresearch Online:  similar ...
Chimerix Initiates Phase 2 Study Of CMX001 In Stem Cell Transplant Recipients Seropositive For Cytomegalovirus
Medical News Today:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Pharma Live:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
KSLA:  similar ...
Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation
Transplant International:  similar ...
Medical News: Chimerix Initiates Phase 2 Study Of CMX001 In Stem Cell Transplant Recipients Seropositive For Cytomegalovirus
BioFind:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
RBC Dain Rauscher:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
South Florida Business Journal:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Triangle Business Journal:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Memphis Business Journal:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Los Angeles Business:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Business Journal of Jacksonville:  similar ...
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Triad Business Journal:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 
BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.